Observational studyCancer communications (London, England)2018

Epidermal growth factor receptor (EGFR) T790M mutation identified in plasma indicates failure sites and predicts clinical prognosis in non-small cell lung cancer progression during first-generation tyrosine kinase inhibitor therapy: a prospective observational study.

Shirong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.